Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction
暂无分享,去创建一个
[1] F. Real,et al. Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer , 1994, International journal of cancer.
[2] Ying Wang,et al. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation , 2002, Journal of Gastroenterology.
[3] L. Pradayrol,et al. Identification of K-ras Mutations in Pancreatic Juice in the Early Diagnosis of Pancreatic Cancer , 1995, Annals of Internal Medicine.
[4] T. Okai,et al. Usefulness of Supernatant of Pancreatic Juice for Genetic Analysis of K-ras in Diagnosis of Pancreatic Carcinoma , 2001, Pancreas.
[5] G. Church,et al. In situ localized amplification and contact replication of many individual DNA molecules. , 1999, Nucleic acids research.
[6] J. Fogh,et al. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.
[7] J. Groffen,et al. c-K-ras mutations in human carcinomas occur preferentially in codon 12. , 1987, Oncogene.
[8] H. Kijima,et al. Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines. , 2001, Oncology reports.
[9] H. Saisho,et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. , 1993, Cancer research.
[10] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[11] R. Weinberg,et al. Cellular oncogenes and multistep carcinogenesis. , 1983, Science.
[12] K. Kinzler,et al. Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[14] G. Cooper,et al. Cellular transforming genes. , 1982, Science.
[15] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[16] G. Adessi,et al. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice , 2001, American Journal of Gastroenterology.
[17] C. Harris,et al. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment. , 1995, Toxicology letters.
[18] J. Hoeijmakers. Genome maintenance mechanisms for preventing cancer , 2001, Nature.
[19] F. Real,et al. Genetic profile of 22 pancreatic carcinoma cell lines , 2001, Virchows Archiv.
[20] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[21] M. Lieber,et al. Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.
[22] R. Weinberg,et al. Tumor suppressor genes. , 1991, Science.
[23] David E. Housman,et al. Digital genotyping and haplotyping with polymerase colonies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Hruban,et al. Loss of heterozygosity or intragenic mutation, which comes first? , 2001, The American journal of pathology.
[25] Bruce A.J. Ponder,et al. Cancer genetics , 2001, Nature.